Previously submitted to: JMIR Formative Research (no longer under consideration since Jun 03, 2024)
Date Submitted: Sep 15, 2023
Open Peer Review Period: Sep 15, 2023 - Nov 10, 2023
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A User-Focused Evaluation of a Clinical Decision Support System for Monitoring Cancer Patient Evolution: Usability Study
ABSTRACT
Background:
Patients with cancer consistently face undesired effects that commonly result in the experience of Adverse Events which negatively impact their overall well-being and quality of life. Therefore, it is crucial having a clinical decision support system that allows monitoring patient’s evolution proactively to prevent and manage complications. However, the success of such systems depends not only on their functionality but also on their usability. Usability evaluation plays a pivotal role in assessing the capacity of these products to be effectively used in real-world scenarios.
Objective:
This research aims to thoroughly test the usability and user-friendliness of Step Proactive medical device, Adverse Events management platform for cancer patients and medical professionals.
Methods:
Methodology employed for usability and satisfaction assessment involved a mixed method approach to obtain a comprehensive understanding of participants experience and objective measure of usability. The test involved usability testing and the System Usability Scale (SUS) evaluation. The testing was conducted with a diverse group of participants, of 6 patients with and six Healthcare Professionals (HCPs).
Results:
The obtained SUS score exceeded 85% for both user groups, classifying Step Proactive as grade A and indicating superior performance of the product from user-perceived usability.
Conclusions:
The assessed digital health medical device demonstrates excellent usability and safety for oncology patients and HCPs. Based on the received constructive feedback, minor improvements were identified for further refinement of the application that do not affect either its intended functionality or overall functioning of the tool.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.